VECO

Veeco

$39.60

+6.48%
Nov 9, 2026
Bobby Quantitative Model
Veeco Instruments Inc. designs, manufactures, and services thin-film process equipment used to fabricate semiconductors and other electronic devices, spanning laser processing, ion beam, MOCVD, SiC CVD, ALD, PVD, and wet processing systems, with the majority of revenue derived from semiconductor customers and from China. The company occupies a niche but technically differentiated position in the semiconductor capital equipment supply chain, selling enabling process tools rather than high-volume commodity equipment, which makes it a leveraged play on advanced packaging, compound semiconductors, and specialty device roadmaps. The current investor debate centers on a sharp divergence between reported fundamentals and stock performance: revenue grew 26.2% year over year to $209.4 million in the September 2026 quarter with net income of $13.6 million, yet the shares have fallen roughly 30% over both the trailing one- and three-month windows as the market digests a violent July-to-November de-rating. Sentiment is further complicated by the company's China and data-storage exposure, thin sell-side coverage, and a recent Northland upgrade to Outperform that has so far failed to arrest the downtrend.

People also watch

Nvidia

Nvidia

NVDA

Analysis
TSMC

TSMC

TSM

Analysis
Broadcom

Broadcom

AVGO

Analysis
Micron Technology

Micron Technology

MU

Analysis
AMD

AMD

AMD

Analysis

BobbyInvestment Opinion: Should I buy VECO Today?

Rating: Hold with a speculative-accumulation bias. The core thesis is that Veeco's reported fundamentals — 26.23% year-over-year revenue growth to $209.38 million in Q3 2026, three consecutive sequential revenue increases, a swing to $13.64 million of net income, and $125.80 million of trailing free cash flow — are materially better than a stock that has fallen 59.96% from its June peak to $37.19, but a broken downtrend, thin three-analyst coverage, and a mixed rating set (Citigroup Buy, Northland Outperform, Barclays Equal Weight, Needham Hold, Goldman Neutral) argue against chasing the position before the next earnings print confirms the earnings base. With no precise consensus price target available in the dataset, the view is anchored on the ~11.9x forward multiple implied by the $3.1273 consensus EPS rather than on an analyst upside figure.

Supporting evidence is genuinely two-sided. On valuation, the 2.55x PS and 1.91x price-to-book are modest for a semicap name, and the ~11.9x forward multiple on consensus EPS sits far below the 47.63x trailing PE, implying the market expects a dramatic earnings ramp; even the low-end $2.6595 estimate implies only ~14.0x. On growth, revenue rose from $158.34 million in Q1 to $193.48 million in Q2 to $209.38 million in Q3, and operating income climbed from $1.23 million to $11.85 million to $14.10 million over the same span, lifting operating margin from 0.78% to 6.73%. On cash, trailing free cash flow of $125.80 million against a $1.69 billion market cap is roughly a 7.4% FCF yield, with a 4.75 current ratio, 0.296 debt-to-equity, and $205.32 million of cash. The offsets are equally concrete: Q3 gross margin of 38.39% is below the 40.35% posted in Q3 2025 and 41.38% in Q2 2025, net margin is only 5.33%, ROE 4.00%, and EV/EBITDA of 26.16x and price-to-cash-flow of 26.56x are rich against the 2.55x sales multiple.

The biggest risks that could invalidate the thesis are a demand air-pocket that forces consensus EPS toward or below the $2.6595 low estimate (which would make the ~11.9x forward multiple an illusion built on stale numbers), further China export-control tightening given the majority-of-revenue China concentration, and continued margin erosion below the high-30s gross margin level. This Hold would upgrade to Buy if Q4 results confirm EPS tracking at or above the $3.13 consensus and gross margin recovers above 40%, or if the stock reclaims the $42-$45 October breakdown zone on volume; it would downgrade to Sell on a decisive break below the $33.25 52-week low or a consensus EPS cut below $2.66. Net verdict: the stock looks undervalued relative to its own multi-year PS band (2.55x versus a 6.93x-to-23.92x historical range) and cheap on forward earnings, but fairly-to-richly valued on trailing cash-flow metrics — a deep-value setup that has not yet been confirmed by price.

Sign up to view all

VECO 12-Month Price Forecast

The forward view is genuinely balanced: the fundamental trajectory (26.23% revenue growth, operating margin expanding from 0.78% to 6.73% across 2026, $125.80 million of trailing free cash flow) supports a re-rating, but the price action (-30.52% in one month, -59.96% max drawdown, 25.53 points of one-month underperformance versus SPY) shows the market has not accepted that trajectory as durable. The pivotal variable is whether the $3.1273 consensus EPS is a credible forward base or a stale estimate — at ~11.9x forward the stock is deeply discounted, but at 47.63x trailing and 26.16x EV/EBITDA it is not cheap if earnings disappoint. Thin coverage of a $1.69 billion market cap means single-analyst actions carry outsized weight, and the 11.85% single-day snap-back from $33.25 to $37.19 on 1.10 million shares shows how violently the stock can move in either direction. I would upgrade to bullish on a Q4 print confirming EPS at or above consensus with gross margin above 40%, and downgrade to bearish on a break below $33.25 or a consensus EPS cut below $2.66.

Historical Price
Current Price $39.60
Average Target $39.60
High Target $45.54
Low Target $33.66

Wall Street consensus

Coverage is thin, with only 3 analysts contributing estimates, and the available institutional ratings show a mixed but recently improving tone. The consensus EPS estimate is $3.1273 (range $2.6595 to $3.30463) on average revenue of $1.116 billion (range $988.0 million to $1.165 billion), which at the current $37.19 price implies a forward multiple of about 11.9x, a level that would ordinarily be considered deeply discounted for a company growing revenue 26%. On ratings, Citigroup has maintained Buy repeatedly through 2026, Northland upgraded to Outperform from Market Perform on September 21, 2026, while Barclays remains Equal Weight, Needham moved to Hold from Buy in October 2025, and Goldman Sachs has stayed Neutral since May 2025, producing a consensus that leans cautiously constructive rather than bullish. A precise average price target is not available in the provided dataset, so implied upside to a consensus target cannot be calculated.

The signal strength from the ratings distribution is moderate at best. The upgrade from Northland and the persistent Citigroup Buy suggest some analysts see the selloff as overdone relative to the fundamental trajectory, while the Needham downgrade to Hold and Goldman's long-standing Neutral reflect concern about cyclicality, China exposure, and margin durability. The EPS estimate range of $2.6595 to $3.30463 is relatively tight (roughly 24% spread from low to high), which implies reasonable conviction in the near-term earnings base rather than wild disagreement, but with only 3 analysts the sample is too small to treat as a robust consensus. Limited coverage of this kind is typical of a small-cap ($1.69 billion market cap) semicap supplier and implies less efficient price discovery, higher volatility, and greater sensitivity to single-analyst actions, which is consistent with the stock's -59.96% drawdown and 11.85% single-day snap-back.

Drowning in data?

Find the real signal!

Bulls vs Bears: VECO Investment Factors

The evidence currently favors the bear side on price action but the bull side on fundamentals, and the market has not yet reconciled the two. Revenue growth of 26.23% year over year, three consecutive sequential increases, a swing to $13.64 million of Q3 net income, $125.80 million of trailing free cash flow, and a ~11.9x forward multiple all argue the selloff is overdone, yet a -59.96% drawdown, -30.52% one-month decline, and 25.53-point relative underperformance versus SPY show momentum remains decisively negative. The single most important tension is whether the $3.13 consensus EPS is a credible forward base or a stale estimate: if Q4 results confirm the earnings ramp, the ~12x forward multiple is a deep-value entry, but if estimates are cut toward the $2.66 low end or below, the trailing 47.6x PE and 26.16x EV/EBITDA look expensive and the downtrend extends. Until the next earnings print resolves that question, the bear case has stronger near-term evidence while the bull case has stronger fundamental support.

Bullish

  • Revenue accelerating three straight quarters: Q3 2026 revenue of $209.38 million rose 26.23% year over year from $165.88 million and climbed sequentially from $193.48 million in Q2 and $158.34 million in Q1. Three consecutive sequential increases point to demand momentum, not a peak, which is fundamentally at odds with a stock down 59.96% from its June high.
  • Forward multiple near 12x on consensus: At $37.19, the analyst consensus EPS of $3.1273 implies a forward multiple of roughly 11.9x, a deep discount for a company growing revenue 26%. Even the low-end estimate of $2.6595 implies about 14.0x, still modest for a semicap name with a 2.55x PS ratio.
  • Fortress balance sheet and strong cash generation: The current ratio is 4.75, debt-to-equity only 0.296, and cash stood at $205.32 million at quarter-end. Trailing free cash flow of $125.80 million against a $1.69 billion market cap implies an FCF yield of roughly 7.4%, a genuine valuation backstop.
  • Profitability inflected sharply upward: Operating income rose from $1.23 million in Q1 to $11.85 million in Q2 to $14.10 million in Q3, lifting operating margin from 0.78% to 6.73%. Net income swung from a -$0.32 million Q1 loss to $13.64 million in Q3, showing operating leverage as volumes scale.

Bearish

  • Violent downtrend with broken momentum: The stock has fallen 30.52% over one month, 29.54% over three months, and 37.41% over six months, with a maximum drawdown of -59.96% from the $83.04 June peak. It trails SPY by 25.53 percentage points over one month, a sign of persistent distribution rather than a single shock.
  • Trailing valuation still expensive: The trailing PE is 47.63x, EV/EBITDA is 26.16x, and price-to-cash-flow is 26.56x, all rich for a company with a 5.33% net margin and 4.00% ROE. The wide gap between 47.6x trailing and ~11.9x forward means the market is either pricing a dramatic earnings ramp or the consensus is stale.
  • Margins below prior-year levels: Q3 2026 gross margin of 38.39% is below the 40.35% posted in Q3 2025 and the 41.38% in Q2 2025, indicating mix and pricing have not fully recovered even as volumes scale. Net margin of 5.33% and ROE of 4.00% remain thin versus larger semicap peers.
  • China and data-storage concentration: The majority of revenue comes from semiconductor customers and from China, and data storage contributed only $20.01 million of Q3's $209.38 million. Geopolitical export-control risk and cyclical storage demand leave the revenue base exposed to factors outside management's control.

VECO Technical Analysis

The prevailing trend is a violent, sustained downtrend that has overwhelmed a still-positive longer-term return. Despite a 1-year price change of +27.58%, the stock has collapsed from an intraperiod peak near $83.04 in mid-June 2026 to $37.19, a maximum drawdown of -59.96%, leaving the shares trading at roughly 45% of the 52-week range (approximately $33.25 low to $83.04 high). That positioning near the lower quartile of the annual range is characteristic of a broken momentum name rather than a healthy consolidation, and it sits in stark contrast to the +9.59% one-year gain in SPY, underscoring how much of VECO's earlier outperformance has been surrendered.

Short-term momentum is decisively negative and accelerating to the downside. The stock is down 30.52% over the past month and 29.54% over three months, with a 6-month change of -37.41%, meaning the decline has persisted across multiple horizons rather than being a single shock. Relative strength confirms the severity: VECO trails SPY by 25.53 percentage points over one month and 24.63 points over three months, even though it still leads by 17.99 points over twelve months. The one glaring counter-signal is the most recent session, in which the stock jumped 11.85% from a $33.25 close to $37.19 on volume of about 1.10 million shares, a sharp snap-back that could mark short-term capitulation and oversold mean reversion, but one green candle inside a -60% drawdown is not a trend reversal.

Key technical levels are now well defined. Support sits at the $33.25 recent low, which also anchors the 52-week floor; a decisive break below that level would confirm a fresh leg lower and likely trigger further momentum-driven selling. Resistance is layered, with the $42-$45 zone (the October breakdown area) as the first hurdle and the $57-$58 region as the more meaningful reclaim level that would be required to neutralize the downtrend. Volatility is extreme by any measure: a -59.96% max drawdown and a 30% one-month decline imply realized volatility far above the market, and while beta is not provided in the dataset, the magnitude of these moves argues for materially reduced position sizing and wider stop-loss bands than a typical large-cap semiconductor holding would require.

Beta

—

—

Max Drawdown

-60.0%

Largest decline past year

52-Week Range

—

Price range past year

Annual Return

+30.2%

Cumulative gain past year

PeriodVECO ReturnS&P 500
1m-24.3%-3.3%
3m-21.0%-2.3%
6m-34.3%+1.4%
1y+30.2%+12.2%
ytd+29.7%+10.4%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

VECO Fundamental Analysis

The revenue trajectory is genuinely strong and improving, which makes the price action all the more notable. Third-quarter 2026 revenue reached $209.38 million, up 26.23% year over year from $165.88 million, and up sequentially from $193.48 million in Q2 and $158.34 million in Q1, marking three consecutive quarters of sequential growth. Segment data shows the semiconductor business contributing $135.25 million, with compound semiconductor at $40.20 million, data storage at $20.01 million, and scientific/other at $13.92 million, indicating that the core semiconductor franchise is carrying the growth while storage remains a smaller, cyclical contributor. The trend implies accelerating demand rather than a peak, which is fundamentally at odds with a stock down nearly 60% from its high.

Profitability has inflected sharply upward over the past three quarters. Q3 2026 net income was $13.64 million (EPS $0.22) on a 38.39% gross margin, up from $11.86 million in Q2 (38.68% gross margin) and a Q1 loss of -$0.32 million on a 34.81% gross margin. Operating income rose to $14.10 million in Q3 from $11.85 million in Q2 and just $1.23 million in Q1, lifting the operating margin to 6.73% from 0.78% earlier in the year, while trailing net margin stands at 5.33% and ROE at 4.00%. Gross margins in the high-30s are respectable for a semicap tool vendor but remain below the 40%+ levels posted in 2024 and early 2025, suggesting mix and pricing have not fully recovered even as volumes scale.

Balance sheet and cash generation are the strongest part of the story. The current ratio is 4.75, debt-to-equity is a modest 0.296, and cash stood at $205.32 million at quarter-end against negligible buybacks or dividends. Free cash flow was $53.59 million in Q3 alone and $125.80 million on a trailing basis, with operating cash flow of $57.92 million against capital expenditure of just $4.33 million, a capital expenditure coverage ratio of 13.38x. That combination of a fortress liquidity position, low leverage, and robust internally generated cash means Veeco does not depend on external financing to fund growth, and the FCF yield of roughly 7.4% on the $1.69 billion market cap offers a genuine valuation backstop for a company with a 4.00% ROE and 5.33% net margin.

Quarterly Revenue

$209384000.0B

2026-09

Revenue YoY Growth

+26.2%

YoY Comparison

Gross Margin

38.4%

Latest Quarter

Free Cash Flow

$125804000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Compound Semiconductor
Data Storage
Scientific And Other
Semiconductor

Open an Account, get $2 TSLA now!

Valuation Analysis: Is VECO Overvalued?

Because net income is positive ($13.64 million in Q3, $0.22 EPS), the PE ratio is the appropriate primary metric, and here the picture is bifurcated. The trailing PE is 47.63x while the forward PE derived from the provided data is -0.88x, a nonsensical negative figure that reflects a data artifact rather than a real forecast; using the analyst consensus EPS of $3.13 instead implies a forward multiple of roughly 11.9x on the $37.19 price. That enormous gap between 47.6x trailing and about 11.9x forward is the crux of the valuation debate: the market is either pricing in a dramatic earnings ramp or the consensus estimate is stale relative to the recent deterioration.

On peer-relative grounds the stock screens cheap on sales but expensive on cash flow. The PS ratio of 2.55x and price-to-book of 1.91x are modest for a semiconductor equipment name, and the 39.95% gross margin and 5.33% net margin are below the profitability profile of larger semicap peers, which argues for a discount rather than a premium. However, the EV/EBITDA of 26.16x and price-to-cash-flow of 26.56x are rich relative to the 2.55x sales multiple, a divergence driven by the still-depressed EBITDA base ($22.96 million in Q3) and heavy non-cash charges; the PEG ratio of -0.88 is not meaningful given the sign issues in the underlying growth inputs.

Historical context is the most damning part of the valuation case. The stock's own PE history shows 58.98x at Q3 2026, 99.74x at Q2, and 386.22x at Q4 2025, while PS has ranged from 6.93x in Q1 2025 to 23.92x in Q2 2026 and now sits at 2.55x. That places the current sales multiple near the very bottom of its multi-year band and the PE well off its recent peak, which is consistent with either a deep value opportunity or a market that expects the earnings base to deteriorate sharply; given the 26% revenue growth and $125.8 million trailing free cash flow, the weight of evidence favors the former, but the -59.96% drawdown signals the market is not yet convinced.

PE

47.6x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 2x~59x

vs. Industry Avg

54.4x

Industry PE ~54.4x*

EV/EBITDA

26.2x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on margin durability and earnings quality rather than solvency. Q3 2026 gross margin of 38.39% sits below the 40.35% recorded in Q3 2025 and the 41.38% in Q2 2025, so even with revenue up 26.23% year over year the company is earning less per dollar of sales than a year ago. Net margin is only 5.33% and ROE 4.00%, meaning the trailing 47.63x PE and 26.16x EV/EBITDA rest on a still-depressed $22.96 million quarterly EBITDA base, and any mix shift or pricing pressure would compress that base quickly. The balance sheet itself is not the problem — current ratio 4.75, debt-to-equity 0.296, $205.32 million of cash — but revenue concentration in semiconductor customers and China, plus a $20.01 million data-storage slice that is cyclical, leaves the top line exposed to a narrow set of end markets.

Market and competitive risks are dominated by valuation compression and cyclicality. The stock has already de-rated 59.96% from its $83.04 June peak to $37.19, and the historical PE band of 386.22x in Q4 2025, 99.74x in Q2 2026, and 58.98x in Q3 2026 shows how violently multiples can move for a small-cap semicap name. With only 3 analysts covering a $1.69 billion market cap, price discovery is inefficient and single-analyst actions carry outsized weight — Needham's October 2025 downgrade to Hold and Goldman's Neutral since May 2025 illustrate the skepticism, while Northland's September 2026 upgrade has so far failed to arrest the decline. Sector rotation away from semicap equipment, export-control headlines tied to China, and the stock's demonstrated ability to move 11.85% in a single session (the November 6 snap-back from $33.25 to $37.19 on 1.10 million shares) all argue for materially reduced position sizing.

The worst-case scenario is a demand air-pocket that forces consensus EPS down toward or below the $2.6595 low estimate while the multiple stays compressed. In that chain of events, Q4 bookings disappoint, China orders slow on export-control tightening, data-storage demand rolls over, and the ~11.9x forward multiple proves to be based on stale numbers rather than a bargain — pushing the stock through the $33.25 52-week low and toward a fresh leg lower. From the current $37.19, a retest of the $33.25 low implies roughly -10.6%, and a break below it with no defined technical floor could extend the drawdown toward the -59.96% magnitude already realized from the June high, implying a theoretical floor near $33 or lower. Realistically, investors should underwrite a -10% to -25% downside from current levels in the adverse case, with the $33.25 support level as the key line in the sand.

FAQ

Ranked by severity: first, earnings-estimate risk — the entire ~11.9x forward case rests on $3.1273 consensus EPS, and a cut toward or below the $2.6595 low would expose the 47.63x trailing PE and 26.16x EV/EBITDA as expensive, likely breaking the $33.25 low. Second, geopolitical and revenue-concentration risk — the majority of revenue comes from semiconductor customers and from China, so new US export-control restrictions on equipment sales could disrupt orders directly, compounded by a cyclical $20.01 million data-storage slice. Third, margin risk — Q3 gross margin of 38.39% is already below the 40.35% in Q3 2025 and 41.38% in Q2 2025, and further erosion would undercut the operating leverage story that took operating margin from 0.78% to 6.73% across 2026. Fourth, market-structure risk — only 3 analysts cover a $1.69 billion market cap, so single-analyst actions carry outsized weight, and the stock's demonstrated 11.85% single-session move (from $33.25 to $37.19) shows how violently it can reprice in either direction.

The 12-month forecast splits into three scenarios. The base case (50% probability, $38-$48) assumes consensus EPS of $3.1273 proves broadly achievable, gross margin stabilizes in the high-30s, China revenue holds, and modest multiple expansion off 2.55x PS carries shares toward the mid-$40s. The bull case (25%, $55-$65) requires Q4 results confirming EPS at or above consensus with gross margin recovering above 40% and a re-rating toward the mid-single-digit PS range the stock held through 2025-2026. The bear case (25%, $25-$33) is a demand air-pocket that forces EPS toward the $2.6595 low, breaks the $33.25 52-week low, and extends the drawdown. The base case is most likely because the fundamental trajectory (26.23% revenue growth, $125.80 million trailing FCF) is real but the market has not yet accepted it as durable; the key assumption is that the $3.13 consensus is a credible forward base rather than a stale estimate.

The valuation is genuinely bifurcated. On forward earnings the stock looks cheap: ~11.9x the $3.1273 consensus EPS, or about 14.0x even at the $2.6595 low estimate, against 26.23% revenue growth. On trailing metrics it looks expensive: 47.63x trailing PE, 26.16x EV/EBITDA, and 26.56x price-to-cash-flow, all rich for a 5.33% net margin and 4.00% ROE. Relative to its own history the sales multiple of 2.55x sits near the very bottom of a multi-year band that ranged from 6.93x in Q1 2025 to 23.92x in Q2 2026, while the PE has compressed from 386.22x in Q4 2025 to 58.98x in Q3 2026. The market is therefore pricing either a dramatic earnings ramp or a deteriorating earnings base — the 2.55x PS and 1.91x price-to-book argue the former, but the -59.96% drawdown shows the market has not yet accepted it. Net: undervalued versus its own sales-multiple history and cheap on forward earnings, but fairly-to-richly valued on trailing cash-flow metrics.

From a risk/reward standpoint VECO offers an asymmetric but unconfirmed setup: at $37.19 the stock trades at roughly 11.9x the $3.1273 consensus EPS and about 2.55x sales, with $125.80 million of trailing free cash flow implying a ~7.4% FCF yield and a fortress balance sheet (4.75 current ratio, 0.296 debt-to-equity, $205.32 million cash). The upside case is a re-rating toward the $55-$65 zone if Q4 confirms the earnings base, while the downside is anchored by the $33.25 52-week low, roughly -10.6% from here, with a break below it risking an extension toward the -59.96% drawdown already realized. The biggest downside risk is that the consensus EPS is stale and gets cut toward the $2.6595 low, which would make the forward multiple an illusion. It is a reasonable buy only for risk-tolerant investors who size positions small and accept a 12-24 month horizon, and it is not a good buy for anyone needing income (0% dividend) or near-term momentum confirmation.

VECO is a long-term, staged-accumulation candidate rather than a short-term trading vehicle. The company is in a mid-cycle earnings recovery — operating margin went from 0.78% in Q1 to 6.73% in Q3 2026 — with a fortress balance sheet (4.75 current ratio, $205.32 million cash) and a 0% dividend, meaning all return must come from price appreciation and there is no income cushion. Volatility is extreme: a -59.96% max drawdown, a -30.52% one-month decline, and an 11.85% single-day snap-back imply realized volatility far above the market, so short-term traders face wide, unpredictable swings with no reliable trend to trade against. Earnings visibility is limited by thin three-analyst coverage and China export-control exposure. A concrete minimum holding period of 12-24 months is appropriate, sized small enough to withstand a retest of the $33.25 low, with position increases reserved for confirmation of EPS at or above $3.13 and gross margin above 40%.